Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$59.18 USD
-1.25 (-2.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $59.17 -0.01 (-0.02%) 7:14 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 0.99 |
EPS Last Quarter | 0.91 |
Last EPS Surprise | 16.67% |
ABR | 1.80 |
Earnings ESP
|
1.01% |
---|---|
Current Year | 3.95 |
Next Year | 4.73 |
EPS (TTM) | 3.27 |
P/E (F1) | 15.32 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 248.77M | 300.94M | 976.94M | 1.15B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 252.46M | 314.63M | 988.30M | 1.18B |
Low Estimate | 240.26M | 289.20M | 963.63M | 1.13B |
Year ago Sales | 216.03M | 230.04M | 829.25M | 976.94M |
Year over Year Growth Est. | 15.16% | 30.82% | 17.81% | 17.33% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.99 | 1.26 | 3.95 | 4.73 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 0.97 | 1.37 | 3.83 | 4.60 |
High Estimate | 1.05 | 1.37 | 4.10 | 5.12 |
Low Estimate | 0.95 | 1.12 | 3.77 | 4.60 |
Year ago EPS | 0.75 | 0.82 | 2.77 | 3.95 |
Year over Year Growth Est. | 32.00% | 53.66% | 42.60% | 19.96% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 3 | 2 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.99 | 1.26 | 3.95 | 4.73 |
7 Days Ago | 0.99 | 1.26 | 3.95 | 4.73 |
30 Days Ago | 1.00 | 1.29 | 3.93 | 4.78 |
60 Days Ago | 1.05 | 1.28 | 3.90 | 4.81 |
90 Days Ago | 1.05 | 1.28 | 3.90 | 4.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.00 | 1.35 | 4.04 | 4.60 |
Zacks Consensus Estimate | 0.99 | 1.26 | 3.95 | 4.73 |
Earnings ESP | 1.01% | 6.97% | 2.41% | -2.82% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.91 | 0.79 | 0.82 | 0.75 | NA |
Estimate | 0.78 | 0.69 | 0.82 | 0.71 | NA |
Difference | 0.13 | 0.10 | 0.00 | 0.04 | 0.07 |
Surprise | 16.67% | 14.49% | 0.00% | 5.63% | 9.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more